OSR Holdings, Inc. (OSRH): Nasdaq/NYSE listing notice — Bellevue Life Sciences receives Nasdaq deficiency notice for minimum public holders

OSR Holdings, Inc.

Received Nasdaq notice on Feb 15, 2024, for failing the minimum 300 public holders requirement (Rule 5550(a)(3)).
Company has 45 calendar days, until April 1, 2024, to submit a plan to regain compliance.
If plan is accepted, Nasdaq may grant an extension of up to 180 days from the notice date.
Notice has no immediate effect on the listing of the company's securities on Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

OSR Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5550(a)(3)

Exact text from the filing

February 15, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the Company no longer meets the minimum 300 public holders requirement for The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(3) (the “ Minimum Public Holders Requirement ”). In accordance with Nasdaq rules, the Company has 45 calendar days, or until April 1, 2024, to submit a plan to regain compliance with the Minimum Public Holders Requirement. If the

View on SEC.gov

Browse all listing & compliance notices →

OSR Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000898432-24-000143

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.